Literature DB >> 27408349

Effective Treatment of a Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm with a Cutaneous Tumor Alone by Stem Cell Transplantation with Reduced Intensity Conditioning.

Maiko Shimomura1, Takaki Asano2, Aya Furue2, Mizuka Miki2, Yasuhiko Sera2, Hiroshi Kawaguchi2, Kazuhiro Nakamura2, Masao Kobayashi2.   

Abstract

Pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy that has an extremely poor prognosis despite the use of intensive chemotherapy. Recently, treatment of BPDCN with bone marrow transplantation (BMT) using myeloablative conditioning has been reported to increase survival in adults. We report a 9-year-old girl with cutaneous BPDCN who was successfully treated with combination chemotherapy followed by BMT using reduced intensity conditioning (RIC), without any adverse complications. The success of this treatment regimen suggests that BMT with RIC may be a feasible option for treating children with cutaneous BPDCN.

Entities:  

Keywords:  Blastic plasmacytoid dendritic cell neoplasm (BPDCN); Cutaneous tumor; Hematopoietic stem cell transplantation (HSCT); Reduced-intensity stem-cell transplantation (RIST)

Year:  2015        PMID： 27408349      PMCID： PMC4925505          DOI： 10.1007/s12288-015-0543-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  25 in total

1.  Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.

Authors:  Keiko Hashikawa; Daisuke Niino; Shinichiro Yasumoto; Takekuni Nakama; Junichi Kiyasu; Kensaku Sato; Yoshizo Kimura; Masanori Takeuchi; Yasuo Sugita; Takashi Hashimoto; Koichi Ohshima
Journal:  J Am Acad Dermatol       Date:  2011-08-11       Impact factor: 11.527

2.  Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.

Authors:  F Julia; T Petrella; M Beylot-Barry; M Bagot; D Lipsker; L Machet; P Joly; O Dereure; M Wetterwald; M d'Incan; F Grange; J Cornillon; G Tertian; E Maubec; P Saiag; S Barete; I Templier; F Aubin; S Dalle
Journal:  Br J Dermatol       Date:  2013-09       Impact factor: 9.302

3.  Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation.

Authors:  Masaki Yamaguchi; Mio Maekawa; Yoshihisa Nakamura; Mikio Ueda
Journal:  Am J Hematol       Date:  2005-10       Impact factor: 10.047

4.  Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.

Authors:  Naoko Murashige; Masahiro Kami; Yukiko Kishi; Sung-Won Kim; Masami Takeuchi; Kosei Matsue; Yoshinobu Kanda; Makoto Hirokawa; Yoshinari Kawabata; Tomoko Matsumura; Eiji Kusumi; Noriyuki Hirabayashi; Koji Nagafuji; Ritsuro Suzuki; Kengo Takeuchi; Kazuo Oshimi
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

Review 5.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Authors:  Michael J Rauh; Fazlur Rahman; David Good; Jeffrey Silverman; Michael K Brennan; Nikolay Dimov; Jane Liesveld; Daniel H Ryan; W Richard Burack; John M Bennett
Journal:  Leuk Res       Date:  2011-09-03       Impact factor: 3.156

6.  Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.

Authors:  Armin G Jegalian; Nataliya P Buxbaum; Fabio Facchetti; Mark Raffeld; Stefania Pittaluga; Alan S Wayne; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

7.  Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

Authors:  Menachem Bitan; Wensheng He; Mei-Jie Zhang; Hisham Abdel-Azim; Mouhab Fakhreddine Ayas; Bella Bielorai; Paul A Carpenter; Mitchell S Cairo; Miguel Angel Diaz; John T Horan; Sonata Jodele; Carrie L Kitko; Kirk R Schultz; Morris Kletzel; Kimberly A Kasow; Leslie E Lehmann; Parinda A Mehta; Nirali Shah; Michael A Pulsipher; Tim Prestidge; Adriana Seber; Shalini Shenoy; Ann E Woolfrey; Lolie C Yu; Stella M Davies
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

8.  Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.

Authors:  Carlo Cota; Esmeralda Vale; Isabel Viana; Luis Requena; Gerardo Ferrara; Lucia Anemona; Dieter Metze; Regina Fink-Puches; Thomas Wiesner; Lorenzo Cerroni
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

Review 9.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

10.  Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.

Authors:  Michael A Pulsipher; Kenneth M Boucher; Donna Wall; Haydar Frangoul; Michel Duval; Rakesh K Goyal; Peter J Shaw; Ann E Haight; Michael Grimley; Stephan A Grupp; Morris Kletzel; Richard Kadota
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113
View more
  1 in total

Review 1.  A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature.

Authors:  Yunning Yang; Yuanyuan Xu; You Nie; Hongwei Wang; Shan Long; Xiaosong Li
Journal:  J Int Med Res       Date:  2019-09-17       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.